SEC Comment Letter for ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL) — Nov 8, 2019
ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221)
Date: Nov. 8, 2019 · CIK: 0001621221 · Accession: 0000000000-19-015344
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234372
Letter
November 7, 2019 Gregory D. Gorgas Chief Executive Officer and President Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla, CA 92037 Re:Artelo Biosciences, Inc. Registration Statement on Form S-3 Filed October 30, 2019 File No. 333-234372 Dear Mr. Gorgas: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Morris at 202-551-3314 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Tom Hornish, Esq.
Show Raw Text
November 7, 2019
Gregory D. Gorgas
Chief Executive Officer and President
Artelo Biosciences, Inc.
888 Prospect Street, Suite 210
La Jolla, CA 92037
Re:Artelo Biosciences, Inc.
Registration Statement on Form S-3
Filed October 30, 2019
File No. 333-234372
Dear Mr. Gorgas:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Morris at 202-551-3314 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Tom Hornish, Esq.